- Email: [email protected]
XAB New developments in biotechnology: U.S. investment in biotechnology, part 4
SPEC|ALREPORTS impact of this evolving technology is assessed.
119 (ERA citation 13:035556)
1347524 PB88-248950/XAB Evaluating EPA's (Enviror~nental Protection Agency's) Current Objectives and Future Needs for Biotechnology Risk A s s e s s ~ t Research. Report of the Biotechnology Research Review Subcommittees (Final report) Environmental Protection Agency, Washington, DC. Science Advisory Board. Report No.: SAB/EETFC-88/010 Jan 88 44p Languages: English NTIS Prices $11.95 Country of Publication: United States The EPA Biotechnology Research Review Subcommittee commends the program and the researchers for the number of significant accomplishments achieved in a short period of time. Preliminary areas of concentration on development of methods were appropriate and now allow the program to shift to application of methods. Specifically, new emphasis should be placed on microcosm and field testing, Investigating and analyzing environmental effects, and developing control strategies for containment and mitigation. The Subcommittee was concerned with the limited scope and lack of strategy for the health effects component, while supporting the strategy underlying the engineering component.
1347408 PB88-246939/XAB New Developments in Biotechnology: U.S. Investment in Biotechnology, Part 4 Also available from Supt. of Docs. See also PB88-143680. Library of Congress catalog card no. 88-600538. Office of Technology Assessment, Washington, DC. Report NO.: OTA-BA-360 Jul 88 300p Languages: English NTIS Prices: $24.95 Country of Publication United States The report describes the levels and types of investment currently being made by the Federal, State and private sectors. It identifies issues that affect investment: ~levels of R&D funding, research priorities, interagency coordination, information requirements, training and education needs, monitoring or university-lndustry research. State efforts to promote biotechnology, the effects of tax law on commercial biotechnology. The adequacy of Federal assistance for biotechnology start-ups and the effects of export control on biotechnology commerce.
1347025 DE88770212/XAB B I O T E C H N I C A H a n o v e r ~87. Conference Abstracts International exhibition and congress for biotechnology (BIOTECHNICA-3) Hanover, F.R. Germany, 22 Sep 1987. U.S. Sales Only. Portions of this document are illegible in microfiche products. Deutsche Messe- und Ausstellungs-A.G., Hanover (Germany, F.R.). Report NO.: CONF-8709271-ABSTS. 1987 67p Languages: English Document Type: Conference proceeding NTIS Prices: $13.95 Country of Publication: Germany, Federal Republic of The conference papers deal with biotechnological processes in the field of medicine, genetic engineering, production of proteins, peptides and hormones.
119 (ERA citation 13:035556)
1347524 PB88-248950/XAB Evaluating EPA's (Enviror~nental Protection Agency's) Current Objectives and Future Needs for Biotechnology Risk A s s e s s ~ t Research. Report of the Biotechnology Research Review Subcommittees (Final report) Environmental Protection Agency, Washington, DC. Science Advisory Board. Report No.: SAB/EETFC-88/010 Jan 88 44p Languages: English NTIS Prices $11.95 Country of Publication: United States The EPA Biotechnology Research Review Subcommittee commends the program and the researchers for the number of significant accomplishments achieved in a short period of time. Preliminary areas of concentration on development of methods were appropriate and now allow the program to shift to application of methods. Specifically, new emphasis should be placed on microcosm and field testing, Investigating and analyzing environmental effects, and developing control strategies for containment and mitigation. The Subcommittee was concerned with the limited scope and lack of strategy for the health effects component, while supporting the strategy underlying the engineering component.
1347408 PB88-246939/XAB New Developments in Biotechnology: U.S. Investment in Biotechnology, Part 4 Also available from Supt. of Docs. See also PB88-143680. Library of Congress catalog card no. 88-600538. Office of Technology Assessment, Washington, DC. Report NO.: OTA-BA-360 Jul 88 300p Languages: English NTIS Prices: $24.95 Country of Publication United States The report describes the levels and types of investment currently being made by the Federal, State and private sectors. It identifies issues that affect investment: ~levels of R&D funding, research priorities, interagency coordination, information requirements, training and education needs, monitoring or university-lndustry research. State efforts to promote biotechnology, the effects of tax law on commercial biotechnology. The adequacy of Federal assistance for biotechnology start-ups and the effects of export control on biotechnology commerce.
1347025 DE88770212/XAB B I O T E C H N I C A H a n o v e r ~87. Conference Abstracts International exhibition and congress for biotechnology (BIOTECHNICA-3) Hanover, F.R. Germany, 22 Sep 1987. U.S. Sales Only. Portions of this document are illegible in microfiche products. Deutsche Messe- und Ausstellungs-A.G., Hanover (Germany, F.R.). Report NO.: CONF-8709271-ABSTS. 1987 67p Languages: English Document Type: Conference proceeding NTIS Prices: $13.95 Country of Publication: Germany, Federal Republic of The conference papers deal with biotechnological processes in the field of medicine, genetic engineering, production of proteins, peptides and hormones.